Presentation OPT-SMC malaria vaccine workshop - Jan 2023
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                BioDrugs. 2023 Sep 20;37(6):737–756. doi: 10.1007/s40259-023-00623-4 
There are many malaria vaccine candidates in development, with more than a dozen of these in clinical development. RTS,S/AS01 (also known as Mosquirix) is the most advanced malaria vaccine and was shown to have modest efficacy ...against clinical malaria in phase III trials in 5- to 17-month-old infants. Following pilot implementation trials, the World Health Organisation has recommended it for use in Africa in young children who are most at risk of infection with P. falciparum, the deadliest of the human malaria parasites.
                                                                    more
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                Preferred product characteristics and clinical development considerations